• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Pharma & HealthcareGlobal Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414289
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 118 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.

Scope of the Report:

This report focuses on the Intravenous (IV) Solutions in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.

The worldwide market for Intravenous (IV) Solutions is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

ICU Medical Inc. (U.S.)

B. Braun Melsungen AG (Germany)

Fresenius Kabi AG (Germany)

Baxter (U.S.)

Amanta Healthcare (India)

Terumo Medical Corporation (Tokyo)

Grifols S.A. (Spain)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Market Segment by Applications, can be divided into

Hospital & Clinics

Ambulatory

Home Care

There are 15 Chapters to deeply display the global Intravenous (IV) Solutions market.

Chapter 1, to describe Intravenous (IV) Solutions Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous (IV) Solutions, with sales, revenue, and price of Intravenous (IV) Solutions, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous (IV) Solutions, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intravenous (IV) Solutions market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intravenous (IV) Solutions sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

1 Market Overview

1.1 Intravenous (IV) Solutions Introduction

1.2 Market Analysis by Type

1.2.1 Peripheral Parenteral Nutrition

1.2.2 Total Parenteral Nutrition

1.3 Market Analysis by Applications

1.3.1 Hospital & Clinics

1.3.2 Ambulatory

1.3.3 Home Care

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ICU Medical Inc. (U.S.)

2.1.1 Business Overview

2.1.2 Intravenous (IV) Solutions Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 B. Braun Melsungen AG (Germany)

2.2.1 Business Overview

2.2.2 Intravenous (IV) Solutions Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Fresenius Kabi AG (Germany)

2.3.1 Business Overview

2.3.2 Intravenous (IV) Solutions Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Baxter (U.S.)

2.4.1 Business Overview

2.4.2 Intravenous (IV) Solutions Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Baxter (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Amanta Healthcare (India)

2.5.1 Business Overview

2.5.2 Intravenous (IV) Solutions Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Terumo Medical Corporation (Tokyo)

2.6.1 Business Overview

2.6.2 Intravenous (IV) Solutions Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Grifols S.A. (Spain)

2.7.1 Business Overview

2.7.2 Intravenous (IV) Solutions Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Intravenous (IV) Solutions Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Intravenous (IV) Solutions Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Intravenous (IV) Solutions Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Intravenous (IV) Solutions Manufacturer Market Share in 2017

3.3.2 Top 6 Intravenous (IV) Solutions Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Intravenous (IV) Solutions Market Analysis by Regions

4.1 Global Intravenous (IV) Solutions Sales, Revenue and Market Share by Regions

4.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Regions (2013-2018)

4.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Regions (2013-2018)

4.2 North America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.3 Europe Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.5 South America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

5 North America Intravenous (IV) Solutions by Countries

5.1 North America Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

5.1.1 North America Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

5.1.2 North America Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

5.2 United States Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

5.3 Canada Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

5.4 Mexico Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6 Europe Intravenous (IV) Solutions by Countries

6.1 Europe Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

6.1.1 Europe Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

6.2 Germany Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.3 UK Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.4 France Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.5 Russia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.6 Italy Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7 Asia-Pacific Intravenous (IV) Solutions by Countries

7.1 Asia-Pacific Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

7.2 China Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.3 Japan Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.4 Korea Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.5 India Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

8 South America Intravenous (IV) Solutions by Countries

8.1 South America Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

8.1.1 South America Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

8.1.2 South America Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

8.3 Argentina Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

8.4 Colombia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9 Middle East and Africa Intravenous (IV) Solutions by Countries

9.1 Middle East and Africa Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.3 UAE Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.4 Egypt Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.5 Nigeria Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.6 South Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

10 Global Intravenous (IV) Solutions Market Segment by Type

10.1 Global Intravenous (IV) Solutions Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Type (2013-2018)

10.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Type (2013-2018)

10.2 Peripheral Parenteral Nutrition Sales Growth and Price

10.2.1 Global Peripheral Parenteral Nutrition Sales Growth (2013-2018)

10.2.2 Global Peripheral Parenteral Nutrition Price (2013-2018)

10.3 Total Parenteral Nutrition Sales Growth and Price

10.3.1 Global Total Parenteral Nutrition Sales Growth (2013-2018)

10.3.2 Global Total Parenteral Nutrition Price (2013-2018)

11 Global Intravenous (IV) Solutions Market Segment by Application

11.1 Global Intravenous (IV) Solutions Sales Market Share by Application (2013-2018)

11.2 Hospital & Clinics Sales Growth (2013-2018)

11.3 Ambulatory Sales Growth (2013-2018)

11.4 Home Care Sales Growth (2013-2018)

12 Intravenous (IV) Solutions Market Forecast (2018-2023)

12.1 Global Intravenous (IV) Solutions Sales, Revenue and Growth Rate (2018-2023)

12.2 Intravenous (IV) Solutions Market Forecast by Regions (2018-2023)

12.2.1 North America Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.2 Europe Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.3 Asia-Pacific Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.4 South America Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.5 Middle East and Africa Intravenous (IV) Solutions Market Forecast (2018-2023)

12.3 Intravenous (IV) Solutions Market Forecast by Type (2018-2023)

12.3.1 Global Intravenous (IV) Solutions Sales Forecast by Type (2018-2023)

12.3.2 Global Intravenous (IV) Solutions Market Share Forecast by Type (2018-2023)

12.4 Intravenous (IV) Solutions Market Forecast by Application (2018-2023)

12.4.1 Global Intravenous (IV) Solutions Sales Forecast by Application (2018-2023)

12.4.2 Global Intravenous (IV) Solutions Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Intravenous (IV) Solutions . Industry analysis & Market Report on Intravenous (IV) Solutions is a syndicated market report, published as Global Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Intravenous (IV) Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy